TherapeuticsMD TXMD
NASDAQ TXMD
$2.19 +0.01 (+0.46%)
At close: Sep 18, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Change in Inventory (2011 - 2022)

TherapeuticsMD's (TXMD) quarterly Change in Inventory came in at $551000.0 in Q3 2022, up 49.73% on a YoY basis from $368000.0 in Q3 2021, and up 119.56% quarter-over-quarter from -$2.8 million in Q2 2022.

Analysis

TherapeuticsMD (TXMD) Change in Inventory (2011 - 2022) Analysis & Trends

TherapeuticsMD (TXMD) has reported Change in Inventory for 12 consecutive years, with $551000.0 the latest figure, recorded in Q3 2022.

  • For the quarter ending Q3 2022, Change in Inventory rose 49.73% year-over-year to $551000.0; the trailing twelve-month figure through Sep 2022 stood at -$588000.0 (down 2000.0% YoY), and the FY2021 full-year result was $711000.0, down 78.69% from the prior year.
  • Change in Inventory rose to $551000.0 in Q3 2022 per TXMD's latest filing, from -$2.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.0 million in Q3 2019 and bottomed at -$2.8 million in Q2 2022.
  • Historically, Change in Inventory has averaged $714490.1 across 5 years, with a median of $497644.0 in 2018.
  • The sharpest annual moves came in 2019 and 2022: Change in Inventory soared 1145.66% in 2019, then slumped 1335.53% in 2022.
  • Over 5 years, Change in Inventory stood at $889449.0 in 2018, then soared by 49.29% to $1.3 million in 2019, then sank by 136.07% to -$479000.0 in 2020, then surged by 154.28% to $260000.0 in 2021, then jumped by 111.92% to $551000.0 in 2022.
  • According to Business Quant data, Change in Inventory over the past three periods registered $551000.0, -$2.8 million, and $1.4 million for Q3 2022, Q2 2022, and Q1 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 571.00 Mn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 143.00 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 36.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 47.15 Mn
10 TherapeuticsMD 25.35 Mn 16.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 551,000.00
Jun 30, 2022 -2.82 Mn
Mar 31, 2022 1.42 Mn
Dec 31, 2021 260,000.00
Sep 30, 2021 368,000.00
Jun 30, 2021 228,000.00
Mar 31, 2021 -145,000.00
Dec 31, 2020 -479,000.00
Sep 30, 2020 -461,000.00
Jun 30, 2020 1.39 Mn
Mar 31, 2020 2.88 Mn
Dec 31, 2019 1.33 Mn
Sep 30, 2019 3.04 Mn
Jun 30, 2019 2.54 Mn
Mar 31, 2019 1.69 Mn
Dec 31, 2018 889,449.00
Sep 30, 2018 497,644.00
Jun 30, 2018 259,705.00
Mar 31, 2018 135,514.00
Dec 31, 2017 191,841.00